Page last updated: 2024-09-04
xylose and misoprostol
xylose has been researched along with misoprostol in 2 studies
Compound Research Comparison
| Studies (xylose) | Trials (xylose) | Recent Studies (post-2010) (xylose) | Studies (misoprostol) | Trials (misoprostol) | Recent Studies (post-2010) (misoprostol) |
|---|---|---|---|---|---|
| 7,016 | 78 | 2,365 | 4,611 | 1,522 | 1,686 |
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Bjarnason, I; Fenn, CG; Lee, CE; Levi, AJ; Menzies, IS; Smethurst, P | 1 |
Trials
1 trial(s) available for xylose and misoprostol
| Article | Year |
|---|---|
Misoprostol reduces indomethacin-induced changes in human small intestinal permeability.
Topics: 3-O-Methylglucose; Adult; Alprostadil; Edetic Acid; Humans; Indomethacin; Intestine, Small; Male; Methylglucosides; Misoprostol; Permeability; Rhamnose; Xylose | 1989 |
Other Studies
1 other study(ies) available for xylose and misoprostol
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |